title: Residual cell content in plasma produced by three centrifugal apheresis procedures.
abstract: BACKGROUND
  Understanding the impact of collection procedures on the residual amount of blood cells in plasma for transfusion and for fractionation is of current interest. This prospective work evaluated plasma donations collected on an apheresis machine (PCS 2, Haemonetics) with three different automatic centrifugal apheresis procedures, currently largely used in the US (Revision G) and in Europe (Revision F), and included a new procedure that uses a high-separation core (HSC) that is designed with a second separation chamber to further separate cells from plasma.
  
  
  METHODS
  A total of 90 collection procedures have been performed from a population of 37 donors, under comprehensively standardized conditions. There were 30 well-matched donors in each group. Plasma aliquots were taken from the plasma units within 30 minutes of the end of the collection procedures and immediately assessed for WBCs, RBCs, PLTs, and supernatant Hb.
  
  
  RESULTS
  In Revision F and Revision G plasma donations, the mean numbers of WBCs were 83.1 x 10(4) and 311 x 10(4) per L; PLTs, 5.01 x 10(9) and 20 x 10(9) per L; and RBCs, 58 x 10(6) and 43 x 10(6) per L, respectively [corrected]. Significantly lower values were found with the HSC procedure (mean WBC, RBC, and PLT counts, 3.01 x 10(4)/L [p < 0.05], 9 x 10(6)/L [p < 0.001], and 3.5 x 10(9)/L [p < 0.001], respectively). The amount of free Hb was similar in all three procedures.
  
  
  CONCLUSIONS
  Significant differences in numbers of cells in plasma were found depending on the centrifugal procedures used and the design of the separation bowl. The lowest level of cell contamination was found with the new HSC bowl, which without a filtration step, yielded plasma that met the standard for WBC-reduced plasma. Plasma collectors can select the most appropriate method of plasma collection based on donor criteria, use of plasma (transfusion, viral inactivation, or fractionation), and local or international regulations, when in place.
authors: Human Plasma Product Services, Lille, France. tburnou@attglobal.net
authors: Thierry
authors: T
authors: Burnouf
authors: Claudia
authors: C
authors: Kappelsberger
authors: Kerstin
authors: K
authors: Frank
authors: Thomas
authors: T
authors: Burkhardt
mesh_terms: D001772:Blood Cell Count; D001781:Blood Component Removal / Q000379:methods*; D002498:Centrifugation; D004906:Erythrocyte Count; D006801:Humans; D007958:Leukocyte Count; D010949:Plasma / Q000166:cytology*; D010976:Platelet Count; D011446:Prospective Studies; D011897:Random Allocation